Glycosylated Biosimilars Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glycosylated Biosimilars Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 mAb
1.2.3 EPO
1.3 Market by Application
1.3.1 Global Glycosylated Biosimilars Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Chronic Diseases
1.3.4 Autoimmune Diseases
1.3.5 Blood Disorders
1.3.6 Growth Hormone Deficiency
1.3.7 Infectious Diseases
1.3.8 Other Diseases
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Glycosylated Biosimilars Market Perspective (2017-2028)
2.2 Glycosylated Biosimilars Growth Trends by Region
2.2.1 Glycosylated Biosimilars Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Glycosylated Biosimilars Historic Market Size by Region (2017-2022)
2.2.3 Glycosylated Biosimilars Forecasted Market Size by Region (2023-2028)
2.3 Glycosylated Biosimilars Market Dynamics
2.3.1 Glycosylated Biosimilars Industry Trends
2.3.2 Glycosylated Biosimilars Market Drivers
2.3.3 Glycosylated Biosimilars Market Challenges
2.3.4 Glycosylated Biosimilars Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Glycosylated Biosimilars Players by Revenue
3.1.1 Global Top Glycosylated Biosimilars Players by Revenue (2017-2022)
3.1.2 Global Glycosylated Biosimilars Revenue Market Share by Players (2017-2022)
3.2 Global Glycosylated Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Glycosylated Biosimilars Revenue
3.4 Global Glycosylated Biosimilars Market Concentration Ratio
3.4.1 Global Glycosylated Biosimilars Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glycosylated Biosimilars Revenue in 2021
3.5 Glycosylated Biosimilars Key Players Head office and Area Served
3.6 Key Players Glycosylated Biosimilars Product Solution and Service
3.7 Date of Enter into Glycosylated Biosimilars Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Glycosylated Biosimilars Breakdown Data by Type
4.1 Global Glycosylated Biosimilars Historic Market Size by Type (2017-2022)
4.2 Global Glycosylated Biosimilars Forecasted Market Size by Type (2023-2028)
5 Glycosylated Biosimilars Breakdown Data by Application
5.1 Global Glycosylated Biosimilars Historic Market Size by Application (2017-2022)
5.2 Global Glycosylated Biosimilars Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Glycosylated Biosimilars Market Size (2017-2028)
6.2 North America Glycosylated Biosimilars Market Size by Country (2017-2022)
6.3 North America Glycosylated Biosimilars Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Glycosylated Biosimilars Market Size (2017-2028)
7.2 Europe Glycosylated Biosimilars Market Size by Country (2017-2022)
7.3 Europe Glycosylated Biosimilars Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Glycosylated Biosimilars Market Size (2017-2028)
8.2 Asia-Pacific Glycosylated Biosimilars Market Size by Country (2017-2022)
8.3 Asia-Pacific Glycosylated Biosimilars Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Glycosylated Biosimilars Market Size (2017-2028)
9.2 Latin America Glycosylated Biosimilars Market Size by Country (2017-2022)
9.3 Latin America Glycosylated Biosimilars Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Glycosylated Biosimilars Market Size (2017-2028)
10.2 Middle East & Africa Glycosylated Biosimilars Market Size by Country (2017-2022)
10.3 Middle East & Africa Glycosylated Biosimilars Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Sandoz
11.1.1 Sandoz Company Detail
11.1.2 Sandoz Business Overview
11.1.3 Sandoz Glycosylated Biosimilars Introduction
11.1.4 Sandoz Revenue in Glycosylated Biosimilars Business (2017-2022)
11.1.5 Sandoz Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Glycosylated Biosimilars Introduction
11.2.4 Pfizer Revenue in Glycosylated Biosimilars Business (2017-2022)
11.2.5 Pfizer Recent Development
11.3 Teva Pahrmaceutical
11.3.1 Teva Pahrmaceutical Company Detail
11.3.2 Teva Pahrmaceutical Business Overview
11.3.3 Teva Pahrmaceutical Glycosylated Biosimilars Introduction
11.3.4 Teva Pahrmaceutical Revenue in Glycosylated Biosimilars Business (2017-2022)
11.3.5 Teva Pahrmaceutical Recent Development
11.4 Celltrion
11.4.1 Celltrion Company Detail
11.4.2 Celltrion Business Overview
11.4.3 Celltrion Glycosylated Biosimilars Introduction
11.4.4 Celltrion Revenue in Glycosylated Biosimilars Business (2017-2022)
11.4.5 Celltrion Recent Development
11.5 Biocon
11.5.1 Biocon Company Detail
11.5.2 Biocon Business Overview
11.5.3 Biocon Glycosylated Biosimilars Introduction
11.5.4 Biocon Revenue in Glycosylated Biosimilars Business (2017-2022)
11.5.5 Biocon Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Glycosylated Biosimilars Introduction
11.6.4 Amgen Revenue in Glycosylated Biosimilars Business (2017-2022)
11.6.5 Amgen Recent Development
11.7 Samsung Biologics
11.7.1 Samsung Biologics Company Detail
11.7.2 Samsung Biologics Business Overview
11.7.3 Samsung Biologics Glycosylated Biosimilars Introduction
11.7.4 Samsung Biologics Revenue in Glycosylated Biosimilars Business (2017-2022)
11.7.5 Samsung Biologics Recent Development
11.8 Mylan
11.8.1 Mylan Company Detail
11.8.2 Mylan Business Overview
11.8.3 Mylan Glycosylated Biosimilars Introduction
11.8.4 Mylan Revenue in Glycosylated Biosimilars Business (2017-2022)
11.8.5 Mylan Recent Development
11.9 Dr. Reddy's Laboratories
11.9.1 Dr. Reddy's Laboratories Company Detail
11.9.2 Dr. Reddy's Laboratories Business Overview
11.9.3 Dr. Reddy's Laboratories Glycosylated Biosimilars Introduction
11.9.4 Dr. Reddy's Laboratories Revenue in Glycosylated Biosimilars Business (2017-2022)
11.9.5 Dr. Reddy's Laboratories Recent Development
11.10 Stada Arzneimittel AG
11.10.1 Stada Arzneimittel AG Company Detail
11.10.2 Stada Arzneimittel AG Business Overview
11.10.3 Stada Arzneimittel AG Glycosylated Biosimilars Introduction
11.10.4 Stada Arzneimittel AG Revenue in Glycosylated Biosimilars Business (2017-2022)
11.10.5 Stada Arzneimittel AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Glycosylated Biosimilars Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of mAb
Table 3. Key Players of EPO
Table 4. Global Glycosylated Biosimilars Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Glycosylated Biosimilars Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Glycosylated Biosimilars Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Glycosylated Biosimilars Market Share by Region (2017-2022)
Table 8. Global Glycosylated Biosimilars Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Glycosylated Biosimilars Market Share by Region (2023-2028)
Table 10. Glycosylated Biosimilars Market Trends
Table 11. Glycosylated Biosimilars Market Drivers
Table 12. Glycosylated Biosimilars Market Challenges
Table 13. Glycosylated Biosimilars Market Restraints
Table 14. Global Glycosylated Biosimilars Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Glycosylated Biosimilars Market Share by Players (2017-2022)
Table 16. Global Top Glycosylated Biosimilars Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glycosylated Biosimilars as of 2021)
Table 17. Ranking of Global Top Glycosylated Biosimilars Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Glycosylated Biosimilars Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Glycosylated Biosimilars Product Solution and Service
Table 21. Date of Enter into Glycosylated Biosimilars Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Glycosylated Biosimilars Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Glycosylated Biosimilars Revenue Market Share by Type (2017-2022)
Table 25. Global Glycosylated Biosimilars Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Glycosylated Biosimilars Revenue Market Share by Type (2023-2028)
Table 27. Global Glycosylated Biosimilars Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Glycosylated Biosimilars Revenue Market Share by Application (2017-2022)
Table 29. Global Glycosylated Biosimilars Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Glycosylated Biosimilars Revenue Market Share by Application (2023-2028)
Table 31. North America Glycosylated Biosimilars Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Glycosylated Biosimilars Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Glycosylated Biosimilars Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Glycosylated Biosimilars Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Glycosylated Biosimilars Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Glycosylated Biosimilars Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Glycosylated Biosimilars Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Glycosylated Biosimilars Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Glycosylated Biosimilars Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Glycosylated Biosimilars Market Size by Country (2023-2028) & (US$ Million)
Table 41. Sandoz Company Detail
Table 42. Sandoz Business Overview
Table 43. Sandoz Glycosylated Biosimilars Product
Table 44. Sandoz Revenue in Glycosylated Biosimilars Business (2017-2022) & (US$ Million)
Table 45. Sandoz Recent Development
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Glycosylated Biosimilars Product
Table 49. Pfizer Revenue in Glycosylated Biosimilars Business (2017-2022) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Teva Pahrmaceutical Company Detail
Table 52. Teva Pahrmaceutical Business Overview
Table 53. Teva Pahrmaceutical Glycosylated Biosimilars Product
Table 54. Teva Pahrmaceutical Revenue in Glycosylated Biosimilars Business (2017-2022) & (US$ Million)
Table 55. Teva Pahrmaceutical Recent Development
Table 56. Celltrion Company Detail
Table 57. Celltrion Business Overview
Table 58. Celltrion Glycosylated Biosimilars Product
Table 59. Celltrion Revenue in Glycosylated Biosimilars Business (2017-2022) & (US$ Million)
Table 60. Celltrion Recent Development
Table 61. Biocon Company Detail
Table 62. Biocon Business Overview
Table 63. Biocon Glycosylated Biosimilars Product
Table 64. Biocon Revenue in Glycosylated Biosimilars Business (2017-2022) & (US$ Million)
Table 65. Biocon Recent Development
Table 66. Amgen Company Detail
Table 67. Amgen Business Overview
Table 68. Amgen Glycosylated Biosimilars Product
Table 69. Amgen Revenue in Glycosylated Biosimilars Business (2017-2022) & (US$ Million)
Table 70. Amgen Recent Development
Table 71. Samsung Biologics Company Detail
Table 72. Samsung Biologics Business Overview
Table 73. Samsung Biologics Glycosylated Biosimilars Product
Table 74. Samsung Biologics Revenue in Glycosylated Biosimilars Business (2017-2022) & (US$ Million)
Table 75. Samsung Biologics Recent Development
Table 76. Mylan Company Detail
Table 77. Mylan Business Overview
Table 78. Mylan Glycosylated Biosimilars Product
Table 79. Mylan Revenue in Glycosylated Biosimilars Business (2017-2022) & (US$ Million)
Table 80. Mylan Recent Development
Table 81. Dr. Reddy's Laboratories Company Detail
Table 82. Dr. Reddy's Laboratories Business Overview
Table 83. Dr. Reddy's Laboratories Glycosylated Biosimilars Product
Table 84. Dr. Reddy's Laboratories Revenue in Glycosylated Biosimilars Business (2017-2022) & (US$ Million)
Table 85. Dr. Reddy's Laboratories Recent Development
Table 86. Stada Arzneimittel AG Company Detail
Table 87. Stada Arzneimittel AG Business Overview
Table 88. Stada Arzneimittel AG Glycosylated Biosimilars Product
Table 89. Stada Arzneimittel AG Revenue in Glycosylated Biosimilars Business (2017-2022) & (US$ Million)
Table 90. Stada Arzneimittel AG Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Glycosylated Biosimilars Market Share by Type: 2021 VS 2028
Figure 2. mAb Features
Figure 3. EPO Features
Figure 4. Global Glycosylated Biosimilars Market Share by Application in 2021 & 2028
Figure 5. Oncology Case Studies
Figure 6. Chronic Diseases Case Studies
Figure 7. Autoimmune Diseases Case Studies
Figure 8. Blood Disorders Case Studies
Figure 9. Growth Hormone Deficiency Case Studies
Figure 10. Infectious Diseases Case Studies
Figure 11. Other Diseases Case Studies
Figure 12. Glycosylated Biosimilars Report Years Considered
Figure 13. Global Glycosylated Biosimilars Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Glycosylated Biosimilars Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Glycosylated Biosimilars Market Share by Region: 2021 VS 2028
Figure 16. Global Glycosylated Biosimilars Market Share by Players in 2021
Figure 17. Global Top Glycosylated Biosimilars Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glycosylated Biosimilars as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Glycosylated Biosimilars Revenue in 2021
Figure 19. North America Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. North America Glycosylated Biosimilars Market Share by Country (2017-2028)
Figure 21. United States Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Glycosylated Biosimilars Market Share by Country (2017-2028)
Figure 25. Germany Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Glycosylated Biosimilars Market Share by Region (2017-2028)
Figure 33. China Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Japan Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. South Korea Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Southeast Asia Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. India Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Australia Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Glycosylated Biosimilars Market Share by Country (2017-2028)
Figure 41. Mexico Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Brazil Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Glycosylated Biosimilars Market Share by Country (2017-2028)
Figure 45. Turkey Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Saudi Arabia Glycosylated Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Sandoz Revenue Growth Rate in Glycosylated Biosimilars Business (2017-2022)
Figure 48. Pfizer Revenue Growth Rate in Glycosylated Biosimilars Business (2017-2022)
Figure 49. Teva Pahrmaceutical Revenue Growth Rate in Glycosylated Biosimilars Business (2017-2022)
Figure 50. Celltrion Revenue Growth Rate in Glycosylated Biosimilars Business (2017-2022)
Figure 51. Biocon Revenue Growth Rate in Glycosylated Biosimilars Business (2017-2022)
Figure 52. Amgen Revenue Growth Rate in Glycosylated Biosimilars Business (2017-2022)
Figure 53. Samsung Biologics Revenue Growth Rate in Glycosylated Biosimilars Business (2017-2022)
Figure 54. Mylan Revenue Growth Rate in Glycosylated Biosimilars Business (2017-2022)
Figure 55. Dr. Reddy's Laboratories Revenue Growth Rate in Glycosylated Biosimilars Business (2017-2022)
Figure 56. Stada Arzneimittel AG Revenue Growth Rate in Glycosylated Biosimilars Business (2017-2022)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Industry Market Size
